Hytn provides strategic supply contracts and selects 4000 kg of mystery for the German market

Item content

Vancouver, March 28, 2025 (Globe Newswire) – Hytn Innovasions Inc (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or “company” or “company”), strategic supply agreements (company “)) and” contracts “) successfully The deck is based on a minimum of 4000 kg of mystery for the German market with a system of good production (GMP). This stage is based on the latest ads, including 4C laboratories, including 4C laboratories, including 4C laboratories, and further strengthens production is the placement.

Item content

Item content

Item content

In February 2025, the contracts were subjected to a serious specialization in the company’s compatibility of the company’s comprehensive site inspections, quality control assessments, quality control assessments, quality control assessments (GACP) compatibility (GACP) compliance (GACP). These agreements provide serious product characteristics, testing protocols and evaluation protocols and evaluation structures, and ensuring a reliable and consistent mystery for Turkey, adaptation of hard microbiological limits and non-radiation requirements. Two cultivator Klonetics plant Science Inc., who are qualified in HYTN’s system for the German market, is another Kelowna company that is not disclosed.

Item content

Item content

Approved cultivation, focusing on high potential cultivation for the German patient, focusing on the German patient’s GMP-certification, ensures that all the secrets of the German GMP-certification will meet the country’s highest drug standards, the country’s demand regulation requirements.

“GMP-certified global demand has increased, HYTN, we committed partnership with the most qualified cultivation to ensure seamless integration into international medical markets,” he said. He added that “We are proud to support the patient’s entrance to premium medical cannabies in Germany, and we look forward to building HYTN as a prevailing partner for pharmaceutical degree in Europe.”

Item content

Germany’s medical sector live rapidly with the patient’s adoption, expansion and expansion of a prescription of the expanding doctor. In 2024, 2013, 20,000 kilograms of medical cannabis were imported in Germany. This increased a quarterly average quarterly average before the regulatory reforms of April 2024 and demonstrated the demand for appropriate drug cannabis products¹.

Hytn, Q2 in 2025 GMP expects the arrival of initial cultivation groups for processing, and in late 2025, Germany is expected to be the first research.

1. Johnny Green, “The significant medical mystery imports increased in S3 in Germany” (2024)

About Hytn Innovations Inc

Hytn Innovations Inc., Psychoactive and psychotropic compounds, including mysterious cannabis and psychotropic compounds, including psychoactive and psychotropic compounds, a drug company specializing in production, marketing and sale. HYTN is dedicated to being the main provider of these products in all federal adjustable markets. The company strategically determines it by defining market opportunities and implements revelation in innovative products through the advanced development platform.

Item content

About good production experiences (GMP)

GMP Instructions provide instructions for production, testing and quality guaranteed to ensure that a product produced is safe for human consumption or use. Many countries have legalized manufacturers to develop GMP rules for their GMP procedures and their own GMP rules in accordance with the legislation.

Contact for more information:

Elliot McKer

CEO

1.866.590.9289

Hytn Investor Relationships:

1.866.590.9289

Investment@hytn.Life

The Canadian Securities Exchange (CSE) This press release has not been approved or not confirmed or refused.

Some information here are forward-looking information covering the risk and uncertainties. The expected secrets of selective secrets for readers and the German market do not need to be placed in new markets or existing markets or more limited statements in existing markets or licensing requirements. Faktiki nəticələrin irəli baxan ifadələrdən fərqli olmasına səbəb ola biləcək amillər və ya şirkətin işinə, performansına, inkişafı və nəticələrinə təsir göstərə bilər, digər şeylər arasında və ya mövcud olanların arasına və ya mövcud bazarlarda və ya mövcud bazarlarda və ya lisenziyalaşdırma və sertifikatlaşdırma standartlarının aparılmasına imkan verməməsi daxildir; changes in regulatory requirements affecting product registration or distribution; changes in market demand for cannabis drinks; Competitive factors in industry; and common economic and business conditions. The historical truth is considered to be made by any statement that there are no statements. The progress in this news broadcasting does not have to make new information, future events or other ways, except for the extent required by this news and the required law. The forward-looking phrases in this news broadcast are openly qualified by this warning note.

Item content